The discovery could lead to novel means to alleviate chronic pain, researchers said.
The researchers were inspired by previous work on memory conducted some fifteen years ago. These studies had revealed that when a memory is reactivated during recall, its neurochemical encoding is temporarily unlocked.
Simultaneous administration of a drug that blocks neurochemical reconsolidation of the memory results in its erasure.
The investigators wanted to see whether a similar mechanism was at play during neurochemical encoding of pain sensitisation.
The procedure, which causes no physical damage, triggers pain hypersensitivity through a process of protein synthesis in the spinal cord.
After capsaicin injections, the mechanical pressure at which mice would flinch was about a third of that in the normal situation.
Three hours later, the researchers administered a second dose of capsaicin and, at the same time, a drug that blocks protein synthesis.
The hypersensitivity then vanished rapidly. Within less than 2 hours, the pressure tolerated by the mice was back to 70 per cent of normal.
The study was published in the journal Nature Neuroscience.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
